Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study

SIMPLE SUMMARY: Trifluridine/tipiracil is an oral combination therapy currently approved as a salvage-line treatment in patients with metastatic colorectal cancer refractory to, or not, candidates for available therapies. However, there is no consensus on the specific factors that should be consider...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Alfonso, Pilar, Muñoz, Andrés, Jiménez-Castro, Jerónimo, Jiménez-Fonseca, Paula, Pericay, Carles, Longo-Muñoz, Federico, Reyna-Fortes, Carmen, Argilés-Martínez, Guillem, González-Astorga, Beatriz, Gómez-Reina, María José, Ruiz-Casado, Ana, Rodríguez-Salas, Nuria, López-López, Rafael, Carmona-Bayonas, Alberto, Conde-Herrero, Verónica, Aranda, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468101/
https://www.ncbi.nlm.nih.gov/pubmed/34572740
http://dx.doi.org/10.3390/cancers13184514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468101/
https://www.ncbi.nlm.nih.gov/pubmed/34572740
http://dx.doi.org/10.3390/cancers13184514

Ejemplares similares